AstraZeneca Medicaid fraud verdict
Executive Summary
An Alabama state judge upholds a jury verdict that found AstraZeneca reported false and misleading drug prices for reimbursement by Alabama's state Medicaid agency. Judge Charles Price let stand the $40 million award of compensatory damages but lowered the $175 million punitive damages award to $120 million. The attorney general of Alabama has sued about 70 drug companies alleging Medicaid fraud. The suit against AstraZeneca was the first to go to trial. Novartis and GlaxoSmithKline are currently on trial before Judge Price in Montgomery County Circuit Court
An Alabama state judge upholds a jury verdict that found AstraZeneca reported false and misleading drug prices for reimbursement by Alabama's state Medicaid agency. Judge Charles Price let stand the $40 million award of compensatory damages but lowered the $175 million punitive damages award to $120 million. The attorney general of Alabama has sued about 70 drug companies alleging Medicaid fraud. The suit against AstraZeneca was the first to go to trial. Novartis and GlaxoSmithKline are currently on trial before Judge Price in Montgomery County Circuit Court. |